We are thrilled to unveil our latest innovation: ELAREM™ Ultimate-FD PLUS The gamma irradiated Human Platelet Lysate ELAREM™ Ultimate-FD PLUS is designed to meet the needs of cell manufacturing applications requiring proven viral reduction. As a xeno-free cell culture supplement, ELAREM™ Ultimate-FD PLUS supports the safe and
We are thrilled to announce a significant milestone for PL BioScience! In a recent press release, we reveal that we have successfully closed a €7.8 million Series A financing round. This Series A funding marks a pivotal moment in our company’s growth journey. This substantial infusion
PL BioScience will be at the virtual Cell Therapy Manufacturing & Gene Therapy Congress 2020 Also this year from October 19 to 22, 2020 we will participate the international congress for Cell & Gene Therapy The year 2020 is a special year and we are glad to
The TechVision Fonds brings in new capital in PL BioScience We are proud to announce that with the support of SilverSky LifeSciences we successfully managed to convince the TechVision Fonds to invest in our start-up business. The TechVision Fonds, managed by the S-UBG group, supports innovative start-up
Meet PL BioScience at the annual GSCN Conference From 23 to 25 September the annual Conference of the German Stem Cell Network (GSCN) will take place. We will be part of it in the virtual exhibition. Special times require special actions Because of the corona safety requirements and
